Navigation Links
Influenza vaccine may reduce risk of heart disease and death
Date:10/27/2012

ative of patients such as those in North America and Canada in particular could help answer this question," he says.

This research could also potentially boost use of the vaccine, which Udell believes is still woefully low. "The use of the vaccine is still much too low, less than 50 per cent of the general population; it's even poorly used among health care workers," he says. "Imagine if this vaccine could also be a proven way to prevent heart disease."

An Ipsos Reid survey conducted by B.C. and Quebec Lung Associations this year found that 36 per cent of Canadians reported having received a flu shot in 2011.

And according to the Public Health Agency of Canada's National Advisory Committee on Immunization (NACI), the 2008 Adult National Immunization Coverage Survey found that vaccination rates for adults 18 to 64 years of age with a chronic medical condition is low at 35 per cent.

It also found that non-institutionalized seniors aged 65 and older have higher coverage, at 66 per cent.

According to the NACI, rates for both groups have declined somewhat since their 2006 survey and fall short of the 80 per cent national targets for influenza vaccine coverage in adults under age 65 with chronic conditions and in seniors.

People with ICDS who get the shot have fewer adverse events The second study, conducted by cardiologists Drs. Ramanan Kumareswaran and Sheldon Singh from Sunnybrook Health Sciences Centre examined the use of the influenza vaccine in patients with implantable cardiac defibrillators or ICDs.

"Anecdotes suggest that patients have more ICD shocks during flu season. We were trying to figure out what we can do to reduce the amount of shocks in (our clinic's) ICD population during the flu season," says Dr. Kumareswaran.

Patients with ICDs that had appointments at the Sunnybrook Hospital ICD clinic between September 1st 2011 and November 31st 2011 completed a survey that identifie
'/>"/>

Contact: Jane-Diane Fraser
jfraser@hsf.ca
613-569-4361 x273
Heart and Stroke Foundation of Canada
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Reconstructed 1918 influenza virus has yielded key insights, scientists say
2. New influenza virus from seals highlights the risks of pandemic flu from animals
3. Measuring the uncertainties of pandemic influenza
4. Cardiff scientists bid to develop anthrax vaccine to counteract world bioterrorism threat
5. Whooping Cough Vaccine Protection Fades Over Time: Study
6. Experimental Dengue Vaccine Shows Some Success
7. Dengue Vaccine Initiative welcomes latest progress in vaccine development
8. RV144 vaccine efficacy increased against certain HIV viruses
9. Too Few Girls Get HPV Vaccine Against Cancer: CDC
10. Cancer turns off important immune cells, complicating experimental vaccine therapies
11. UTMB receives $1.2 million to provide HPV vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... CO (PRWEB) November 22, 2014 ... growth equity investments in the consumer brand sector, ... The investment will be used to help fund ... product pipeline rollout, particularly its proprietary apparel and ... will join BackJoy’s Board of Directors. , BackJoy ...
(Date:11/22/2014)... A Xarelto lawsuit has been filed on behalf of ... in damages from the makers and marketers of the ... woman began using Xarelto in March 2012 and used it ... suffered life-threatening bleeding in July 2012 and as a result, ... distress. The lawsuit purports that the woman’s injuries are due ...
(Date:11/22/2014)... Nov. 21, 2014 (HealthDay News) -- The widely used ... death and hospitalization among patients who have the heart ... failure, a new study finds. Atrial fibrillation is ... linked to a rise in risk for stroke among ... a century to help treat irregular heartbeat, the authors ...
(Date:11/21/2014)... Nov. 20, 2014 (HealthDay News) -- Seeking to make ... U.S. Food and Drug Administration on Thursday approved a ... Hydrocodone -- best known by the brand name ... been tied to a surge in dangerous addictions across ... approved Hysingla ER (hydrocodone bitartrate) is an extended-release tablet ...
(Date:11/21/2014)... MLF Biotech, Inc. has developed a ... Probiotics for Pets helps maintain digestive health and can ... intestinal flora after it experiences a period of stress, ... for Pets is a proprietary blend of pure probiotics ... active bacteria strains that are safe and effective for ...
Breaking Medicine News(10 mins):Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 3Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 2Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 3Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 4Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 3Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 3Health News:MLF Biotech Introduces Liv-Pro Probiotics for Pets 2
... , BIRMINGHAM, Ala., Aug. 19 ... more individuals, organizations, and society will continue to ... and communication technology or (ICT). With an ever-expanding ... GASICORP, worldwide leader in information and communication technology, ...
... CHICAGO, Aug. 19 As Electronic Health Record (EHR) Solution Providers race ... e ntric, Inc , offers practical advice for evaluating and designing ... We b i nars will highlight techniques used ... clinician performance while increasing adoption. , , Measuring and improving ...
... NEW YORK, Aug. 19 Bayard Advertising Agency, Inc., ... clients in a broad array of industries, announces its selection ... (HCA) West Florida Division. , , ... notes Jennifer Berres, VP Human Resources for HCA West Florida ...
... ... have a healthier lifestyle by health experts from Avon Obesity Service. , ... (PRWEB) August 19, 2009 -- A smoking alternative has been suggested ... ,Patients have been introduced to the Intellicig electronic cigarettes at Avon Obesity ...
... Biotech Ltd.,(NYSE Amex: SVA ), a leading developer and provider ... and six-,month periods ended June 30, 2009. , , ... to $20.0 million, -- Sales for the six-month period ... the quarter rose 52% to $10.7 million, -- Operating ...
... responsible for more than two thirds of the total ... newly adapted low-dose technique called adaptive statistical iterative reconstruction ... from CT up to 65 percent, according to a ... American Journal of Roentgenology (AJR). Iterative ...
Cached Medicine News:Health News:Are You Connected? AIM and GASICORP Expand Global Reach Through Landmark Strategic Alliance 2Health News:Are You Connected? AIM and GASICORP Expand Global Reach Through Landmark Strategic Alliance 3Health News:User Centric to Present Health IT Usability Webinar Series 2Health News:Bayard Advertising Appointed by Hospital Corporation of America (HCA) West Florida Division for Recruitment Advertising and Employment Branding 2Health News:Health Experts Praise Intellicig Electronic Cigarette 2Health News:Health Experts Praise Intellicig Electronic Cigarette 3Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 2Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 3Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 4Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 5Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 6Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 7Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 8Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 9Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 10Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 11Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 12Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 13Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 14
(Date:11/22/2014)... 2014 Research and Markets  has announced the ... Report, 2014-2017" report to their offering. ... recombinant protein drug market has been expanding rapidly owing ... the like. During 2005-2013, sales of recombinant protein drugs ... of 19.1%, and it is projected that ...
(Date:11/21/2014)... SAN DIEGO , Nov. 21, 2014 /PRNewswire/ ... TNDM ), a medical device company and ... today announced a partnership with Tidepool, a non-profit ... an open source software platform that increases diabetes ... the Tidepool Platform, which is currently under development, ...
(Date:11/21/2014)... , Nov. 21, 2014  Abaxis, Inc. (NasdaqGS: ... point-of-care instruments and consumables for the medical, research, and ... the veterinary and research markets in the ... a stock purchase agreement to acquire 100% of QCR ... based distribution organization. The transaction closed on ...
Breaking Medicine Technology:China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4
... Inc.,(NYSE:MDT) today announced that a review of ... that the trial has met its primary,non-inferiority ... a randomized, single-blind,trial evaluating the safety and ... as compared to the TAXUS Paclitaxel-Eluting,Coronary Stent ...
... Cardiovascular Target from Lexicon's Genetic,Research -, ... /PRNewswire-FirstCall/ --,Lexicon Pharmaceuticals, Inc. today reported ... directed to a,potential new target, angiopoietin-like ... cholesterol. Research suggests that,a monoclonal antibody ...
Cached Medicine Technology:ENDEAVOR IV Clinical Trial Meets Primary Endpoint 2Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 2Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 3Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 4Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 5
Non-dissolvable Herrick Lacrimal Plugs provide long-term lacrimal occlusion through partial blockage of the horizontal canaliculus....
Provides quick freezing and quick defrosting. Lightweight probe tips have high conductivity silver. Useful for Cataract, Retinal Detachment, Glaucoma and Intra-vitreal surgery. Includes either one ca...
Khosla Precision and Quality in Medical and Surgical Products....
Khosla Precision and Quality in Medical and Surgical Products....
Medicine Products: